| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acquisition and expression of ethanol-induced conditioned place preference in mice is inhibited by naloxone
|
Wróbel, Małgorzata
|
|
2011
|
63 |
1 |
p. 79-85
7 p.
|
article
|
| 2 |
Acquisition and expression of ethanol-induced conditioned place preference in mice is inhibited by naloxone
|
Wróbel, Małgorzata
|
|
|
63 |
1 |
p. 79-85
|
article
|
| 3 |
Activation of opioid receptors in injured nerves is required for efficient analgesia in neuropathic pain
|
Labuz, Dominika
|
|
2011
|
63 |
1 |
p. 239-
1 p.
|
article
|
| 4 |
Advances in structure-activity studies of endomorphins
|
Tóth, Géza
|
|
2011
|
63 |
1 |
p. 211-
1 p.
|
article
|
| 5 |
Advances in structure-activity studies of endomorphins
|
Tóth, Géza
|
|
|
63 |
1 |
p. 211
|
article
|
| 6 |
A general introduction to the endocannabinoid system and its interactions with opioid receptor signalling
|
Di Marzo, Vincenzo
|
|
|
63 |
1 |
p. 219
|
article
|
| 7 |
A global view of drug-induced gene expression alterations in the striatum
|
Korostynski, Michał
|
|
2011
|
63 |
1 |
p. 217-
1 p.
|
article
|
| 8 |
A global view of drug-induced gene expression alterations in the striatum
|
Korostynski, Michał
|
|
|
63 |
1 |
p. 217
|
article
|
| 9 |
Alterations of the mGluR5, vasopressin and oxytocin receptor systems induced by chronic opioid administration and withdrawal
|
Bailey, Alexis
|
|
2011
|
63 |
1 |
p. 218-
1 p.
|
article
|
| 10 |
Alterations of the mGluR5, vasopressin and oxytocin receptor systems induced by chronic opioid administration and withdrawal
|
Bailey, Alexis
|
|
|
63 |
1 |
p. 218
|
article
|
| 11 |
Ameliorative potential of sodium cromoglycate and diethyldithiocarbamic acid in restraint stress-induced behavioral alterations in rats
|
Manchanda, Rajneet K.
|
|
2011
|
63 |
1 |
p. 54-63
10 p.
|
article
|
| 12 |
Ameliorative potential of sodium cromoglycate and diethyldithiocarbamic acid in restraint stress-induced behavioral alterations in rats
|
Manchanda, Rajneet K.
|
|
|
63 |
1 |
p. 54-63
|
article
|
| 13 |
Analgesic effects of immune cells in neuropathic pain
|
Machelska, Halina
|
|
2011
|
63 |
1 |
p. 214-
1 p.
|
article
|
| 14 |
Analgesic effects of immune cells in neuropathic pain
|
Machelska, Halina
|
|
|
63 |
1 |
p. 214
|
article
|
| 15 |
A novel family of minimalist opioid peptides deprived of the classic pharmacophores
|
Gentilucci, Luca
|
|
2011
|
63 |
1 |
p. 212-
1 p.
|
article
|
| 16 |
A novel family of minimalist opioid peptides deprived of the classic pharmacophores
|
Gentilucci, Luca
|
|
|
63 |
1 |
p. 212
|
article
|
| 17 |
A novel mechanism of signal transmission: “prototypical” interactions of neuropeptides with plasma membrane
|
Yakovleva, Tatiana
|
|
2011
|
63 |
1 |
p. 237-238
2 p.
|
article
|
| 18 |
Antidepressant-like activity of the phenylpiperazine pyrrolidin-2-one derivatives in mice
|
Sapa, Jacek
|
|
2011
|
63 |
1 |
p. 71-78
8 p.
|
article
|
| 19 |
Antidepressant-like activity of thephenylpiperazinepyrrolidin-2-one derivatives in mice
|
Sapa, Jacek
|
|
|
63 |
1 |
p. 71-78
|
article
|
| 20 |
Antinociceptive effect induced by combination of opioid and neurotensin pharmacophores and their hybrid peptide [Ile9]PK20
|
Kleczkowska, Patrycja
|
|
2011
|
63 |
1 |
p. 245-
1 p.
|
article
|
| 21 |
A prototype cannabinoid receptor 1 antagonist rimonabant decreases μ-opiod receptor G-protein activation in mice forebrain
|
Zádor, Ferenc
|
|
2011
|
63 |
1 |
p. 249-250
2 p.
|
article
|
| 22 |
A putative pharmacophore model of μ-opioid receptor activity
|
Borics, Attila
|
|
2011
|
63 |
1 |
p. 227-228
2 p.
|
article
|
| 23 |
A role for epigenetic mechanisms in the regulation of prodynorphin expression by alcohol
|
D’Addario, Claudio
|
|
2011
|
63 |
1 |
p. 208-209
2 p.
|
article
|
| 24 |
A role for epigenetic mechanisms in the regulation of prodynorphin expression by alcohol
|
D’Addario, Claudio
|
|
|
63 |
1 |
p. 208-209
|
article
|
| 25 |
Atorvastatin affects the tissue concentration of hydrogen sulfide inmouse kidneys and other organs*
|
Wiliński, Bogdan
|
|
2011
|
63 |
1 |
p. 184-188
5 p.
|
article
|
| 26 |
Atorvastatin affects the tissue concentration of hydrogen sulfide in mouse kidneys and other organs
|
Wiliński, Bogdan
|
|
|
63 |
1 |
p. 184-188
|
article
|
| 27 |
Autocrine regulation of human sperm motility by met-enkephalin
|
Subiran, Nerea
|
|
2011
|
63 |
1 |
p. 261-
1 p.
|
article
|
| 28 |
Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data
|
Chrościńska-Krawczyk, Magdalena
|
|
2011
|
63 |
1 |
p. 12-18
7 p.
|
article
|
| 29 |
Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data
|
Chrościńska-Krawczyk, Magdalena
|
|
|
63 |
1 |
p. 12-18
|
article
|
| 30 |
Cannabidiol affects body weight gain and adipose tissue accumulation in rats
|
Ignatowska-Jankowska, Bogna
|
|
2011
|
63 |
1 |
p. 249-
1 p.
|
article
|
| 31 |
Cardiorespiratory effects of morphine and chimeric peptide in anaesthetized rats
|
Wojciechowski, Piotr
|
|
2011
|
63 |
1 |
p. 228-
1 p.
|
article
|
| 32 |
Cell-penetrating peptides modulate the vascular action of phenylephrine
|
Kocić, Ivan
|
|
2011
|
63 |
1 |
p. 195-199
5 p.
|
article
|
| 33 |
Cell-penetrating peptides modulate the vascular action of phenylephrine
|
Kocić, Ivan
|
|
|
63 |
1 |
p. 195-199
|
article
|
| 34 |
Cell-type specific regulation of SGK1 isoforms by morphine and dexamethasone
|
Ślęzak, Michał
|
|
2011
|
63 |
1 |
p. 258-
1 p.
|
article
|
| 35 |
Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in the kainic acid model of epilepsy
|
Bojnik, Engin
|
|
2011
|
63 |
1 |
p. 250-
1 p.
|
article
|
| 36 |
Chronic pain: learning from research into the neurobiology of addiction
|
Hunt, Stephen P.
|
|
2011
|
63 |
1 |
p. 206-
1 p.
|
article
|
| 37 |
Chronic pain: learning from research into the neurobiology of addiction
|
Hunt, Stephen P.
|
|
|
63 |
1 |
p. 206
|
article
|
| 38 |
Combinatory effects of PBDEs and 17β-estradiol on MCF-7 cell proliferation and apoptosis
|
Patrycja, Kwiecińska
|
|
2011
|
63 |
1 |
p. 189-194
6 p.
|
article
|
| 39 |
Combinatory effects of PBDEs and 17β-estradiol on MCF-7 cell proliferation and apoptosis
|
Kwiecińska, Patrycja
|
|
|
63 |
1 |
p. 189-194
|
article
|
| 40 |
CP154,526, a selective inhibitor of CRF 1 receptor, blocks the acquisition of opioid withdrawal-induced conditioned place aversion in mice
|
González-Cuello, Ana
|
|
2011
|
63 |
1 |
p. 253-
1 p.
|
article
|
| 41 |
Cytoprotective action of the potassium channel opener NS1619 under conditions of disrupted calcium homeostasis
|
Chmielewska, Ludwika
|
|
2011
|
63 |
1 |
p. 176-183
8 p.
|
article
|
| 42 |
Cytoprotective action of the potassium channel opener NS1619 under conditions of disrupted calcium homeostasis
|
Chmielewska, Ludwika
|
|
|
63 |
1 |
p. 176-183
|
article
|
| 43 |
Design and synthesis of opioid peptide analogues and mimetics
|
De Marco, Rossella
|
|
2011
|
63 |
1 |
p. 226-
1 p.
|
article
|
| 44 |
Design, synthesis and pharmacological evaluation of novel endomorphin analogues with multiple structural modifications
|
Mallareddy, Jayapal Reddy
|
|
2011
|
63 |
1 |
p. 230-
1 p.
|
article
|
| 45 |
Development of new opioid agonist tachykinin antagonist chimeric compounds
|
Dyniewicz, Jolanta
|
|
2011
|
63 |
1 |
p. 232-
1 p.
|
article
|
| 46 |
Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization
|
Walstab, Jutta
|
|
2011
|
63 |
1 |
p. 45-53
9 p.
|
article
|
| 47 |
Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization
|
Walstab, Jutta
|
|
|
63 |
1 |
p. 45-53
|
article
|
| 48 |
Different mechanisms of opioid action
|
Pilar, Almela
|
|
2011
|
63 |
1 |
p. 222-
1 p.
|
article
|
| 49 |
Discovery of novel κ opioid receptor ligands
|
Spetea, Mariana
|
|
2011
|
63 |
1 |
p. 211-
1 p.
|
article
|
| 50 |
Discovery of novel κ opioid receptor ligands
|
Spetea, Mariana
|
|
|
63 |
1 |
p. 211
|
article
|
| 51 |
Disposition of opiate medications by human placenta
|
Ahmed, Mahmoud S.
|
|
2011
|
63 |
1 |
p. 254-
1 p.
|
article
|
| 52 |
Dose-dependent potentiation by the δ antagonist cha-TIPPpsi on the spinal antinociceptive effect of the μ agonist DAMGO in opioid-naive rats
|
Szentirmay, Apolka K.
|
|
2011
|
63 |
1 |
p. 241-242
2 p.
|
article
|
| 53 |
Dynorphin mutations cause human neurodegenerative disorder spinocerebellar ataxia type 23: a novel non-receptor mechanism of cell signaling?
|
Bakalkin, Georgy
|
|
2011
|
63 |
1 |
p. 208-
1 p.
|
article
|
| 54 |
Dynorphin mutations cause human neurodegenerative disorder spinocerebellar ataxia type 23: a novel non-receptor mechanism of cell signaling?
|
Bakalkin, Georgy
|
|
|
63 |
1 |
p. 208
|
article
|
| 55 |
Dynorphins in experimental Parkinson’s disease revealed by imaging mass spectrometry
|
Bakalkin, Georgy
|
|
|
63 |
1 |
p. 207
|
article
|
| 56 |
Dynorphins in neurological and mental disorders
|
Andersson, Malin
|
|
2011
|
63 |
1 |
p. 207-
1 p.
|
article
|
| 57 |
Dynorphins regulate the intensity of fear memory: from mice to men
|
Bilkei-Gorzo, Andras
|
|
2011
|
63 |
1 |
p. 209-
1 p.
|
article
|
| 58 |
Dynorphins regulate the intensity of fear memory: from mice to men
|
Bilkei-Gorzo, Andras
|
|
|
63 |
1 |
p. 209
|
article
|
| 59 |
Editorial
|
|
|
2011
|
63 |
1 |
p. 1-
1 p.
|
article
|
| 60 |
Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epileptic patients: the influence of co-medication
|
Mathieu, Olivier
|
|
2011
|
63 |
1 |
p. 86-94
9 p.
|
article
|
| 61 |
Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epilepticpatients: the influence of co-medication
|
Mathieu, Olivier
|
|
|
63 |
1 |
p. 86-94
|
article
|
| 62 |
Ejaculatory dysfunction in streptozotocin-induced diabetic rats: the role of testosterone
|
Pontes, Davi A.
|
|
2011
|
63 |
1 |
p. 130-138
9 p.
|
article
|
| 63 |
Ejaculatory dysfunction in streptozotocin-induced diabetic rats: the role of testosterone
|
Pontes, Davi A.
|
|
|
63 |
1 |
p. 130-138
|
article
|
| 64 |
Endocannabinoid catabolic enzyme inhibitors reduce opioid withdrawal responses
|
Lichtman, Aron
|
|
2011
|
63 |
1 |
p. 220-221
2 p.
|
article
|
| 65 |
Endocannabinoid catabolic enzyme inhibitors reduce opioid withdrawal responses
|
Lichtman, Aron
|
|
|
63 |
1 |
p. 220-221
|
article
|
| 66 |
Endocannabinoid system protects against cryptogenic seizures
|
Clementina M., van Rijn
|
|
2011
|
63 |
1 |
p. 165-168
4 p.
|
article
|
| 67 |
Endocannabinoid system protects against cryptogenic seizures
|
van Rijn, Clementina M.
|
|
|
63 |
1 |
p. 165-168
|
article
|
| 68 |
Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia
|
Szliszka, Ewelina
|
|
2011
|
63 |
1 |
p. 139-148
10 p.
|
article
|
| 69 |
Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia
|
Szliszka, Ewelina
|
|
|
63 |
1 |
p. 139-148
|
article
|
| 70 |
Evaluation of constrained amino acids in the design of neurokinin 1 receptor- and bifunctional opioid – neurokinin 1 receptor ligands
|
Ballet, Steven
|
|
2011
|
63 |
1 |
p. 229-
1 p.
|
article
|
| 71 |
Evaluation of the irritating influence of carane derivatives and their antioxidant properties in a deoxyribose degradation test
|
Moniczewski, Andrzej
|
|
2011
|
63 |
1 |
p. 120-129
10 p.
|
article
|
| 72 |
Evaluation of the irritating influence of carane derivatives and their antioxidant properties in a deoxyribose degradation test
|
Moniczewski, Andrzej
|
|
|
63 |
1 |
p. 120-129
|
article
|
| 73 |
Expression regulation of opioid propeptides and dopamine receptors in the mesostriatal system by chronic intake of palatable foods
|
Ziółkowska, Barbara
|
|
2011
|
63 |
1 |
p. 259-
1 p.
|
article
|
| 74 |
δFosB expression in the brain stress system from adrenalectomized rats during morphine dependence
|
Milanés, Maria Victoria
|
|
2011
|
63 |
1 |
p. 255-256
2 p.
|
article
|
| 75 |
Functional selectivity of µ-opioid receptor ligands
|
Koch, Thomas
|
|
|
63 |
1 |
p. 216
|
article
|
| 76 |
Genetic ablation of δ opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes analgesia
|
Weibel, Raphael
|
|
2011
|
63 |
1 |
p. 243-
1 p.
|
article
|
| 77 |
Glial activation and opioid analgesia in neuropathic pain
|
Mika, Joanna
|
|
2011
|
63 |
1 |
p. 214-215
2 p.
|
article
|
| 78 |
Glial activation and opioid analgesia in neuropathic pain
|
Mika, Joanna
|
|
|
63 |
1 |
p. 214-215
|
article
|
| 79 |
Glucocorticoid (GC) receptor antagonist mifepristone attenuates morphine withdrawal behaviors
|
Navarro-Zaragoza, Javier
|
|
2011
|
63 |
1 |
p. 253-254
2 p.
|
article
|
| 80 |
Glutamate inputs to catecholamine pathways shape behavioral effects of addictive drugs
|
Parkitna, Jan Rodriguez
|
|
2011
|
63 |
1 |
p. 217-218
2 p.
|
article
|
| 81 |
Glutamate inputs to catecholamine pathways shape behavioral effects of addictive drugs
|
Parkitna, Jan Rodriguez
|
|
|
63 |
1 |
p. 217-218
|
article
|
| 82 |
H-Dmt-DLys-Phe-Phe-OH, a tetrapeptide metabolite of the opioid-neurotensin hybrid pepide PK20, expresses high antinociception
|
Kleczkowska, Patrycja
|
|
2011
|
63 |
1 |
p. 244-245
2 p.
|
article
|
| 83 |
Heme oxygenase/carbon monoxide-biliverdin pathway may be involved in the antinociceptive activity of etoricoxib, a selective COX-2 inhibitor
|
Grangeiro, Niedja M.G.
|
|
2011
|
63 |
1 |
p. 112-119
8 p.
|
article
|
| 84 |
Heme oxygenase/carbon monoxide-biliverdin pathway may be involved in the antinociceptive activity of etoricoxib, a selective COX-2 inhibitor
|
Grangeiro, Niedja M. G.
|
|
|
63 |
1 |
p. 112-119
|
article
|
| 85 |
Hippocampal transcriptome associated with stress-induced analgesia phenotype in mice – involvement of nts2 receptors
|
Lisowski, Pawel
|
|
2011
|
63 |
1 |
p. 247-
1 p.
|
article
|
| 86 |
Homer proteins regulate the heroin-induced rewarding effect under neuropathic pain
|
Obara, Ilona
|
|
2011
|
63 |
1 |
p. 224-
1 p.
|
article
|
| 87 |
Homer proteins regulate the heroin-induced rewarding effect under neuropathic pain
|
Obara, Ilona
|
|
|
63 |
1 |
p. 224
|
article
|
| 88 |
IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders
|
Strzępa, Anna
|
|
2011
|
63 |
1 |
p. 30-44
15 p.
|
article
|
| 89 |
IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders
|
Strzępa, Anna
|
|
|
63 |
1 |
p. 30-44
|
article
|
| 90 |
Induction of P450 3A1/2 and 2C6 by gemfibrozil in Sprague-Dawley rats
|
Liu, Aiming
|
|
2011
|
63 |
1 |
p. 157-164
8 p.
|
article
|
| 91 |
Induction of P450 3A1/2 and 2C6 by gemfibrozil in Sprague-Dawley rats
|
Liu, Aiming
|
|
|
63 |
1 |
p. 157-164
|
article
|
| 92 |
Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia
|
Łapiński, Łukasz
|
|
2011
|
63 |
1 |
p. 149-156
8 p.
|
article
|
| 93 |
Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia
|
Łapiński, Łukasz
|
|
|
63 |
1 |
p. 149-156
|
article
|
| 94 |
Investigation on DNA methylation status of opioid peptides promoters in PBMCs of subjects with bipolar disorder
|
Benedetto, Manuela Di
|
|
2011
|
63 |
1 |
p. 263-264
2 p.
|
article
|
| 95 |
Involvement of the cannabinoid system in the antinociception induced by opioids
|
Desroches, Julie
|
|
2011
|
63 |
1 |
p. 220-
1 p.
|
article
|
| 96 |
Involvement of the cannabinoid system in the antinociception induced by opioids
|
Desroches, Julie
|
|
|
63 |
1 |
p. 220
|
article
|
| 97 |
Involvement of the endocannabinoid system and nitric oxide pathway in opioid analgesia in a rat model of neuropathic pain
|
Makuch, Wioletta
|
|
2011
|
63 |
1 |
p. 251-
1 p.
|
article
|
| 98 |
Lack of agonist-induced desensitization of μ-opioid receptors located at nerve terminals
|
Denise Lowe, Janet
|
|
2011
|
63 |
1 |
p. 235-
1 p.
|
article
|
| 99 |
L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry
|
Hanrieder, Jörg
|
|
2011
|
63 |
1 |
p. 264-
1 p.
|
article
|
| 100 |
Lymphocyte-suppressing effect of simvastatin in mixed dyslipidemic patients but not impaired glucose tolerance patients
|
Krysiak, Robert
|
|
2011
|
63 |
1 |
p. 95-101
7 p.
|
article
|
| 101 |
Lymphocyte-suppressing effect of simvastatin in mixed dyslipidemic patients but not impaired glucose tolerance patients
|
Krysiak, Robert
|
|
|
63 |
1 |
p. 95-101
|
article
|
| 102 |
Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania
|
Barbosa, Francisco J.
|
|
2011
|
63 |
1 |
p. 64-70
7 p.
|
article
|
| 103 |
Magnesium sulfate and sodium valproate block methylphenidate-inducedhyperlocomotion, an animal model of mania
|
Barbosa, Francisco J.
|
|
|
63 |
1 |
p. 64-70
|
article
|
| 104 |
Melatonin in experimental seizures and epilepsy
|
Banach, Monika
|
|
2011
|
63 |
1 |
p. 1-11
11 p.
|
article
|
| 105 |
Melatonin in experimental seizures and epilepsy
|
Banach, Monika
|
|
|
63 |
1 |
p. 1-11
|
article
|
| 106 |
Metabotropic mGluR5- and adenosine A2A-receptor interactions in opioid addiction
|
Rose Smith, Sherie
|
|
2011
|
63 |
1 |
p. 225-
1 p.
|
article
|
| 107 |
Metabotropic mGluR5- and adenosine A2A-receptor interactions in opioid addiction
|
Smith, Sherie Rose
|
|
|
63 |
1 |
p. 225
|
article
|
| 108 |
Molecular mechanism of drugs of abuse
|
Koch, Thomas
|
|
2011
|
63 |
1 |
p. 216-
1 p.
|
article
|
| 109 |
Morphine and Botulinum neurotoxin A: a successful pharmacological combination against pain?
|
Vacca, Valentina
|
|
2011
|
63 |
1 |
p. 215-
1 p.
|
article
|
| 110 |
Morphine and Botulinum neurotoxin A: a successful pharmacological combination against pain?
|
Vacca, Valentina
|
|
|
63 |
1 |
p. 215
|
article
|
| 111 |
Morphine withdrawal induces the activation of the orexinergic neurons in the rat lateral hypothalamus
|
Núñez, Cristina
|
|
2011
|
63 |
1 |
p. 256-
1 p.
|
article
|
| 112 |
Morphine withdrawal regulatesphosphorylation of heat shockprotein 27 through extracellular-signal-regulated kinase in the heart
|
Pilar, Almela
|
|
|
63 |
1 |
p. 222
|
article
|
| 113 |
Naloxone influences the morphine-induced enhancement of plasma β-endorphin in stress-resistant pigs
|
Ciepielewski, Ziemowit
|
|
2011
|
63 |
1 |
p. 260-
1 p.
|
article
|
| 114 |
Nigral dynorphin peptide levels are associated with L-DOPA-induced dyskinesia
|
Karlsson, Anna
|
|
2011
|
63 |
1 |
p. 261-262
2 p.
|
article
|
| 115 |
7-Nitroindazole, but not NG-nitro-L-arginine, enhances the anticonvulsant activity of pregabalin in the mouse maximal electroshock-induced seizure model
|
J. Łuszczki, Jarogniew
|
|
2011
|
63 |
1 |
p. 169-175
7 p.
|
article
|
| 116 |
7-Nitroindazole, but not NG-nitro-L-arginine, enhances the anticonvulsant activity of pregabalin in the mouse maximal electroshock-induced seizure model
|
Łuszczki, Jarogniew J.
|
|
|
63 |
1 |
p. 169-175
|
article
|
| 117 |
Noradrenaline release in rodent tissues is inhibited by interleukin-1β but is not affected by urotensin II, MCH, NPW and NPFF
|
Schulte, Kirsten
|
|
2011
|
63 |
1 |
p. 102-111
10 p.
|
article
|
| 118 |
Noradrenaline release in rodent tissues is inhibited by interleukin-1ß but is not affected by urotensin II, MCH, NPW and NPFF
|
Schulte, Kirsten
|
|
|
63 |
1 |
p. 102-111
|
article
|
| 119 |
Note to Contributors
|
|
|
2011
|
63 |
1 |
p. 267-269
3 p.
|
article
|
| 120 |
Novel ligands interacting with opioid receptors
|
Cami-Kobeci, Gerta
|
|
2011
|
63 |
1 |
p. 210-
1 p.
|
article
|
| 121 |
Novel opioid peptides from genomic data banks: phylogenetic and bioactivity studies
|
Bojnik, Engin
|
|
2011
|
63 |
1 |
p. 227-
1 p.
|
article
|
| 122 |
Opioid and anti-opioid peptides derived from plant proteins
|
Yoshikawa, Masaaki
|
|
2011
|
63 |
1 |
p. 229-230
2 p.
|
article
|
| 123 |
κ-opioid and cannabinoid-1 receptors mediate anti-inflammatory and antinociceptive effect of salvinorin a on experimental colitis in mice
|
Fichna, Jakub
|
|
2011
|
63 |
1 |
p. 248-
1 p.
|
article
|
| 124 |
Opioid-cannabinoid interactions
|
Di Marzo, Vincenzo
|
|
2011
|
63 |
1 |
p. 219-
1 p.
|
article
|
| 125 |
Opioid-like immunoreactivity in the mamillary body of the guinea pig in fetal and postnatal stages of development
|
Żakowski, Witold
|
|
2011
|
63 |
1 |
p. 262-
1 p.
|
article
|
| 126 |
δ-opioid receptor activation leads to neurite outgrowth and neuronal survival via a STAT5B-Gαi/o pathway
|
Georganta, Eirini-Maria
|
|
2011
|
63 |
1 |
p. 237-
1 p.
|
article
|
| 127 |
μ-opioid receptor (MOR) expression and opioid-mediated intracellular signalling are altered in glial cells exposed to TNF-α
|
Bedini, Andrea
|
|
2011
|
63 |
1 |
p. 223-
1 p.
|
article
|
| 128 |
µ-opioid receptor (MOR) expression and opioid-mediated intracellular signalling are altered in glial cells exposed to TNF-α
|
Bedini, Andrea
|
|
|
63 |
1 |
p. 223
|
article
|
| 129 |
Opioids and immune system
|
Sacerdote, Paola
|
|
2011
|
63 |
1 |
p. 213-
1 p.
|
article
|
| 130 |
Opioids and immune system
|
Sacerdote, Paola
|
|
|
63 |
1 |
p. 213
|
article
|
| 131 |
Opioids and the apoptotic pathway in MCF-7 breast cancer cell line
|
Gach, Katarzyna
|
|
2011
|
63 |
1 |
p. 234-
1 p.
|
article
|
| 132 |
Opioids involvement in the regulation of metabolic syndrome
|
Pierzchala-Koziec, Krystyna
|
|
2011
|
63 |
1 |
p. 263-
1 p.
|
article
|
| 133 |
Peripheral and central analgesic effects of novel opioid peptides
|
Lesniak, Anna
|
|
2011
|
63 |
1 |
p. 223-224
2 p.
|
article
|
| 134 |
Peripheral and central analgesic effects of novel opioidpeptides
|
Lesniak, Anna
|
|
|
63 |
1 |
p. 223-224
|
article
|
| 135 |
Persistent brain region-specific upregulation of vasopressin (V1ar) and oxytocin receptors in chronic intermittent escalating dose morphine administration in mice
|
Zanos, Panos
|
|
2011
|
63 |
1 |
p. 252-
1 p.
|
article
|
| 136 |
Protein kinase Cε as a cancer marker and target for anticancer therapy
|
Totoń, Ewa
|
|
2011
|
63 |
1 |
p. 19-29
11 p.
|
article
|
| 137 |
Protein kinase Cε as a cancer marker and target for anticancer therapy
|
Totoń, Ewa
|
|
|
63 |
1 |
p. 19-29
|
article
|
| 138 |
PS I-1
|
De Marco, Rossella
|
|
|
63 |
1 |
p. 226
|
article
|
| 139 |
PS I-10
|
Fichna, Jakub
|
|
|
63 |
1 |
p. 232-233
|
article
|
| 140 |
PS I-8
|
Novoa, Alexandre
|
|
|
63 |
1 |
p. 231
|
article
|
| 141 |
PS I-6
|
Yoshikawa, Masaaki
|
|
|
63 |
1 |
p. 229-230
|
article
|
| 142 |
PS I-9
|
Dyniewicz, Jolanta
|
|
|
63 |
1 |
p. 232
|
article
|
| 143 |
PS I-5
|
Ballet, Steven
|
|
|
63 |
1 |
p. 229
|
article
|
| 144 |
PS I-7
|
Mallareddy, Jayapal Reddy
|
|
|
63 |
1 |
p. 230
|
article
|
| 145 |
PS I-4
|
Wojciechowski, Piotr
|
|
|
63 |
1 |
p. 228
|
article
|
| 146 |
PS I-3
|
Borics, Attila
|
|
|
63 |
1 |
p. 227-228
|
article
|
| 147 |
PS I-2
|
Bojnik, Engin
|
|
|
63 |
1 |
p. 227
|
article
|
| 148 |
PS II-5
|
Georganta, Eirini-Maria
|
|
|
63 |
1 |
p. 237
|
article
|
| 149 |
PS II-6
|
Yakovleva, Tatiana
|
|
|
63 |
1 |
p. 237-238
|
article
|
| 150 |
PS II-1
|
Gach, Katarzyna
|
|
|
63 |
1 |
p. 234
|
article
|
| 151 |
PS II-3
|
Zádor, Ferenc
|
|
|
63 |
1 |
p. 235-236
|
article
|
| 152 |
PS II-2
|
Lowe, Janet Denise
|
|
|
63 |
1 |
p. 235
|
article
|
| 153 |
PS II-4
|
Papakonstantinou, Maria-P.
|
|
|
63 |
1 |
p. 236
|
article
|
| 154 |
PS III-12
|
Lisowski, Pawel
|
|
|
63 |
1 |
p. 247
|
article
|
| 155 |
PS III-10
|
Al-Khrasani, Mahmoud
|
|
|
63 |
1 |
p. 246
|
article
|
| 156 |
PS III-4
|
Szentirmay, Apolka K.
|
|
|
63 |
1 |
p. 241-242
|
article
|
| 157 |
PS III-1
|
Labuz, Dominika
|
|
|
63 |
1 |
p. 239
|
article
|
| 158 |
PS III-2
|
Rojewska, Ewelina
|
|
|
63 |
1 |
p. 240
|
article
|
| 159 |
PS III-3
|
Király, Kornél
|
|
|
63 |
1 |
p. 241
|
article
|
| 160 |
PS III-9
|
Kleczkowska, Patrycja
|
|
|
63 |
1 |
p. 245
|
article
|
| 161 |
PS III-7
|
Lackó, Erzsébet
|
|
|
63 |
1 |
p. 244
|
article
|
| 162 |
PS III-6
|
Weibel, Raphael
|
|
|
63 |
1 |
p. 243
|
article
|
| 163 |
PS III-5
|
Szentirmay, Apolka
|
|
|
63 |
1 |
p. 242
|
article
|
| 164 |
PS III-11
|
Kosson, Anna
|
|
|
63 |
1 |
p. 246-247
|
article
|
| 165 |
PS III-8
|
Kleczkowska, Patrycja
|
|
|
63 |
1 |
p. 244-245
|
article
|
| 166 |
PS IV-2
|
Ignatowska-Jankowska, Bogna
|
|
|
63 |
1 |
p. 249
|
article
|
| 167 |
PS IV-4
|
Bojnik, Engin
|
|
|
63 |
1 |
p. 250
|
article
|
| 168 |
PS IV-5
|
Makuch, Wioletta
|
|
|
63 |
1 |
p. 251
|
article
|
| 169 |
PS IV-3
|
Zádor, Ferenc
|
|
|
63 |
1 |
p. 249-250
|
article
|
| 170 |
PS IV -1
|
Fichna, Jakub
|
|
|
63 |
1 |
p. 248
|
article
|
| 171 |
PSV-4
|
Ahmed, Mahmoud S.
|
|
|
63 |
1 |
p. 254
|
article
|
| 172 |
PSV-10
|
Ślęzak, Michał
|
|
|
63 |
1 |
p. 258
|
article
|
| 173 |
PSV-8
|
Taverner, Alistair
|
|
|
63 |
1 |
p. 257
|
article
|
| 174 |
PSV-5
|
Laorden, Maria Luisa
|
|
|
63 |
1 |
p. 255
|
article
|
| 175 |
PSV-9
|
Lasheras, Carmen
|
|
|
63 |
1 |
p. 257-258
|
article
|
| 176 |
PSV-7
|
Núñez, Cristina
|
|
|
63 |
1 |
p. 256
|
article
|
| 177 |
PSV-6
|
Milanés, Maria Victoria
|
|
|
63 |
1 |
p. 255-256
|
article
|
| 178 |
PSV-2
|
González-Cuello, Ana
|
|
|
63 |
1 |
p. 253
|
article
|
| 179 |
PSV-11
|
Ziółkowska, Barbara
|
|
|
63 |
1 |
p. 259
|
article
|
| 180 |
PSV-3
|
Navarro-Zaragoza, Javier
|
|
|
63 |
1 |
p. 253-254
|
article
|
| 181 |
PS V-1
|
Zanos, Panos
|
|
|
63 |
1 |
p. 252
|
article
|
| 182 |
PS VI-6
|
Di Benedetto, Manuela
|
|
|
63 |
1 |
p. 263-264
|
article
|
| 183 |
PS VI-3
|
Karlsson, Anna
|
|
|
63 |
1 |
p. 261-262
|
article
|
| 184 |
PS VI-2
|
Subiran, Nerea
|
|
|
63 |
1 |
p. 261
|
article
|
| 185 |
PS VI-5
|
Pierzchala-Koziec, Krystyna
|
|
|
63 |
1 |
p. 263
|
article
|
| 186 |
PS VI-1
|
Ciepielewski, Ziemowit
|
|
|
63 |
1 |
p. 260
|
article
|
| 187 |
PS VI-4
|
Żakowski, Witold
|
|
|
63 |
1 |
p. 262
|
article
|
| 188 |
PS VI-7
|
Hanrieder, Jörg
|
|
|
63 |
1 |
p. 264
|
article
|
| 189 |
Regulation of cannabinoid receptors Type 1 and μ opioid receptors by micro RNA
|
Kraus, Jürgen
|
|
2011
|
63 |
1 |
p. 221-
1 p.
|
article
|
| 190 |
Regulation of cannabinoid receptors Type 1 and µ opioid receptors by micro RNA
|
Kraus, Jürgen
|
|
|
63 |
1 |
p. 221
|
article
|
| 191 |
RGS2 and RGS4 proteins act as novel modulators of κ and δ opioid receptors signaling
|
Papakonstantinou, Maria-P.
|
|
2011
|
63 |
1 |
p. 236-
1 p.
|
article
|
| 192 |
Role of CRFR1 in the activation of catecholaminergic neurons from ventrolateral medulla during naloxone-induced morphine withdrawal
|
Laorden, Maria Luisa
|
|
2011
|
63 |
1 |
p. 255-
1 p.
|
article
|
| 193 |
Role of the corticotropin-releasing factor receptor-1 in the conditioned preference place induced by morphine in mice
|
Lasheras, Carmen
|
|
2011
|
63 |
1 |
p. 257-258
2 p.
|
article
|
| 194 |
Sadowski mice as a model of blood brain barrier variability
|
Kosson, Anna
|
|
2011
|
63 |
1 |
p. 246-247
2 p.
|
article
|
| 195 |
Structural modification and biological evaluation of Dmt1-DALDA analogues
|
Novoa, Alexandre
|
|
2011
|
63 |
1 |
p. 231-
1 p.
|
article
|
| 196 |
Synthesis and in vitro characterization of new salvinorin a analogs incorporating natural amino acids
|
Fichna, Jakub
|
|
2011
|
63 |
1 |
p. 232-233
2 p.
|
article
|
| 197 |
The antihyperalgesic and acute antinociceptive effects of intrathecally injected DAMGO, endomorphin 2 and the endomorphin 2 biosynthesis inducers ILE-PRO-ILE and vildagliptin in rats
|
Szentirmay, Apolka
|
|
2011
|
63 |
1 |
p. 242-
1 p.
|
article
|
| 198 |
The antinociceptive effects of central versus peripheral µ-opioid agonists in a rat model of visceral pain
|
Al-Khrasani, Mahmoud
|
|
2011
|
63 |
1 |
p. 246-
1 p.
|
article
|
| 199 |
The Editors of the Pharmacological Reports wish to thank the following persons
|
|
|
2011
|
63 |
1 |
p. 265-266
2 p.
|
article
|
| 200 |
The effect of sodium ion on μ-opioid receptor G-protein activation
|
Zádor, Ferenc
|
|
2011
|
63 |
1 |
p. 235-236
2 p.
|
article
|
| 201 |
The influence of minocycline on injury-induced changes in dynorphin and nociceptin expression and effects of KOP and NOP receptor ligands in a rat model of neuropathic pain
|
Rojewska, Ewelina
|
|
2011
|
63 |
1 |
p. 240-
1 p.
|
article
|
| 202 |
The in vitro and in vivo pharmacology of c-14-substituted agonist and antagonist opioids
|
Lackó, Erzsébet
|
|
2011
|
63 |
1 |
p. 244-
1 p.
|
article
|
| 203 |
The possible role of endomorphin 2 biosynthesis and CART peptide in the nociceptive information processing in rat spinal dorsal horn: pharmacology and immunohistochemistry
|
Király, Kornél
|
|
2011
|
63 |
1 |
p. 241-
1 p.
|
article
|
| 204 |
Therapeutic potential of κ opioids
|
Chavkin, Charles
|
|
2011
|
63 |
1 |
p. 205-
1 p.
|
article
|
| 205 |
Therapeutic potential of κ opioids
|
Chavkin, Charles
|
|
|
63 |
1 |
p. 205
|
article
|
| 206 |
Transdermal delivery of a buprenorphine/naltrexone combination for the treatment of polydrug abuse
|
Taverner, Alistair
|
|
2011
|
63 |
1 |
p. 257-
1 p.
|
article
|
| 207 |
Universal opioid receptor ligands — buprenorphine and related orvinols
|
Cami-Kobeci, Gerta
|
|
|
63 |
1 |
p. 210
|
article
|
Journal description